Item has been added

Get 20% off!arrow_drop_up

Lactobacillus Gasseri Dosage for Weight Loss: Why 15 Billion CFU Works Best

  • person My Store Admin
  • calendar_today
  • comment 0 comments
Infographic summarizing Lactobacillus gasseri dosage for weight loss, showing recommended CFU range, key factors affecting results, and 8–12 week timeline.

Lactobacillus Gasseri Dosage for Weight Loss: Clinical Evidence & Optimal Use

You've likely heard that certain probiotic strains can support weight management. Among them, Lactobacillus gasseri stands out with the most clinical evidence for reducing abdominal fat. But knowing the right dosage is just the starting point.

The real question isn't simply "how much?" but rather "how much, delivered how, and supported by what?" Clinical trials reveal that identical CFU counts produce vastly different outcomes depending on capsule technology, prebiotic pairing, and whether you're taking a single strain or a synergistic blend. These dietary supplements work differently based on their formulation quality and delivery mechanisms.

Beyond fat loss, L. gasseri research shows effects on the immune system and overall metabolic function. This guide breaks down the clinical dosing data, explains why delivery method matters more than most people realize, and shows you how to maximize your results with proper prebiotic support and multi-strain formulations.

Key Takeaways

Question Answer
What's the effective dosage? Clinical studies show 1-10 billion CFU daily produces measurable fat loss, with most trials using 5-10 billion CFU for 12 weeks
Does CFU count alone determine results? No—delivery method, prebiotic support, and multi-strain synergy dramatically impact survival and colonization in your gut
Which strain matters most? BNR17 and SBT2055 show the strongest clinical evidence, though strain-level effects share similar fat-reduction mechanisms
How long until you see results? Visceral fat reduction becomes measurable at 8-12 weeks with consistent daily use and proper prebiotic feeding
What amplifies effectiveness? Acid-resistant capsules, prebiotic fibers like inulin and acacia, and complementary strains (especially soil-based organisms) boost colonization up to 10x

Understanding Lactobacillus Gasseri and Its Weight Loss Mechanisms

Lactobacillus gasseri is a lactic acid-producing bacterium naturally found in human breast milk and the gastrointestinal tract. Unlike many probiotic strains studied primarily for digestive comfort, this particular strain has been specifically investigated for its effects on body composition and metabolic health.[1]

The strain works through several interconnected pathways. Research shows it modulates adipose tissue gene expression, reducing the activity of genes responsible for fat storage while upregulating those involved in fat breakdown.[2] Specifically, L. gasseri influences lipogenic genes in white adipose tissue, reducing mRNA expression of enzymes like acetyl-CoA carboxylase and fatty acid synthase that drive fatty acid synthesis.

At the same time, the strain enhances fatty acid oxidation by increasing expression of genes like carnitine palmitoyl-transferase 1 and acyl CoA oxidase.[16] This dual action—suppressing fat storage while promoting fat burning—makes L. gasseri particularly effective for body composition changes. The strain also appears to influence inflammatory markers in visceral adipose tissue deposits, which play a central role in metabolic dysfunction.

What makes Lactobacillus gasseri particularly interesting is its specificity for abdominal adiposity. While general weight loss can occur anywhere in the body, this strain shows preferential effects on visceral fat—the metabolically active fat surrounding your organs that contributes most significantly to health risks.[3] The strain appears to target obesity-related genes that specifically govern visceral adipose tissue accumulation and inflammatory responses in metabolically active fat deposits.

How It Differs From Other Probiotic Strains

Not all probiotic supplements affect body composition equally. Other Lactobacillus species may support digestive health or immune function without measurable effects on fat mass. Lactobacillus gasseri distinguishes itself through its influence on lipid metabolism and its ability to colonize the gastrointestinal tract in ways that specifically impact energy regulation.

Studies comparing different Lactobacillus species show that this particular strain produces unique metabolites that interact with fat cells differently than strains like L. acidophilus or L. rhamnosus.[4] This strain-specific activity underscores why choosing dietary supplements with documented strains matters more than simply selecting any product labeled "probiotic."

Clinical Evidence: What the Studies Show About Dosage

The most compelling data comes from controlled human trials that isolated L. gasseri and measured body composition changes over 8-12 weeks. Let's examine what these studies reveal about effective dosing.

The BNR17 Trial: Visceral Fat Reduction at 5 Billion CFU

A randomized, double-blind study published in the Journal of Medicinal Food examined 62 adults with abdominal obesity who received either 5 billion CFU of Lactobacillus gasseri BNR17 daily or a placebo for 12 weeks.[5] The Lactobacillus gasseri BNR17 strain, originally isolated from human breast milk, showed remarkable specificity for white adipose tissue reduction.

Participants taking the probiotic experienced an average 4.6% reduction in visceral fat area measured by computed tomography scan, along with decreased waist circumference and body weight. White adipose tissue weight decreased significantly in the supplementation group, while body mass index improvements exceeded the placebo group by 1.4%.[5]

Bar chart comparing visceral fat and white adipose tissue reduction between placebo and Lactobacillus gasseri BNR17 groups, showing significant decreases at 5 billion CFU dosage.

The control group showed no significant changes. This trial established 5 billion CFU as a clinically effective minimum dose when delivered consistently over three months, with effects on both visceral adiposity and overall white adipose tissue distribution.

The SBT2055 Study: Higher Doses and Abdominal Adiposity

Japanese researchers investigated Probiotic Lactobacillus gasseri SBT2055 in fermented milk at approximately 10 billion CFU daily. This 12-week trial of 87 subjects with high visceral adiposity showed significant reductions in abdominal visceral and subcutaneous fat areas, body weight, body mass index, waist and hip circumferences.[6]

Bar graph from the SBT2055 study showing greater reductions in visceral fat, subcutaneous fat, and body weight for participants taking 10 billion CFU of Lactobacillus gasseri compared to placebo.

Notably, benefits disappeared within four weeks after stopping supplementation, suggesting that ongoing colonization support matters as much as initial dosing. The Lactobacillus gasseri SBT2055 strain demonstrated similar mechanisms to BNR17 but at a higher daily dose, providing evidence that the 5-10 billion CFU range produces consistent effects across different strain variants.

Dose-Response Relationships

When comparing trials, a pattern emerges: doses between 1-5 billion CFU show modest effects, while 5-10 billion CFU produce more consistent and measurable results. Higher doses beyond 10 billion CFU haven't been extensively studied for L. gasseri specifically, though safety data suggests they're well-tolerated.[7]

The takeaway: 5-10 billion CFU appears to be the sweet spot based on current clinical evidence, with 12 weeks representing the minimum intervention period for measurable body composition changes.

Beyond Fat Loss: Metabolic and Digestive Benefits

Clinical trials reveal that L. gasseri affects more than just adipose tissue. Studies in diabetic mouse models showed the strain significantly reduced fasting blood sugar and improved glucose levels over 8-week interventions.[17] These metabolic improvements occurred alongside reductions in body weight, suggesting the strain influences multiple pathways in metabolic health.

Infographic highlighting metabolic and digestive benefits of Lactobacillus gasseri, showing icons for improved blood sugar control and gastrointestinal relief alongside human digestive system imagery.

The digestive system benefits as well. Many participants report improved regularity and reduced bloating within the first month of supplementation. While these effects aren't the primary focus of weight loss studies, they indicate broader gastrointestinal tract optimization that supports overall health.[1]

Why CFU Count Tells Only Part of the Story

Here's where the conversation gets more sophisticated. You could consume 50 billion CFU daily, but if those bacteria don't survive stomach acid or colonize your gut effectively, you're wasting your money.

Survival Through the Digestive Tract

Stomach acid destroys up to 99% of bacteria in standard gelatin or HPMC capsules. This means a product claiming 10 billion CFU might deliver only 100 million viable cells to your intestines—well below the clinical threshold.[8]

Pullulan capsules offer superior acid resistance compared to conventional options. These plant-derived capsules maintain structural integrity through your stomach's harsh environment, releasing bacteria primarily in the intestinal tract where they need to colonize.

MicroBiome Restore Probiotic Infographic with Fermented pullulan prebiotic capsule illustration and Soil-Based Probiotic Benefits

This delivery technology can increase viable cell delivery by 5-10 times compared to standard capsules. Suddenly, that 5 billion CFU dose becomes functionally equivalent to 25-50 billion CFU in a less protective format.

The Critical Role of Prebiotics

Even if bacteria reach your intestines alive, they need food to thrive. Without prebiotic fibers, Lactobacillus gasseri struggles to establish a foothold in your existing microbiome.

Inulin and acacia senegal serve as preferred fuel sources for beneficial bacteria. Clinical data shows that prebiotic supplementation alongside probiotic supplements produces significantly greater improvements in gut microbiota composition than probiotics alone.[9]

When this probiotic strain receives adequate prebiotic support, it produces more short-chain fatty acids—particularly acetate, propionate, and butyrate—that directly influence fat metabolism and appetite regulation. Short-chain fatty acids also strengthen the gut lining and improve nutrient absorption.[24] Without this nutritional foundation, even high-dose probiotic therapy underperforms.

Combining probiotic supplements with fermented foods like kimchi, sauerkraut, and kefir can further enhance colonization. These fermented foods contain both live cultures and the metabolites produced during fermentation, creating a more hospitable environment for incoming probiotic strains.

The Multi-Strain Advantage: Why Isolation Isn't Ideal

Most clinical trials isolate single strains to prove causation. But your gut contains thousands of bacterial species that interact in complex ways. Emerging evidence suggests L. gasseri works more effectively when paired with complementary organisms.

Animal Models and Metabolic Insights

Research using high fat diet-fed mice provides mechanistic insights into how L. gasseri works at the molecular level. In these high-sucrose diet models, the strain prevented weight gain and improved lipid profiles even when animals consumed obesogenic diets.[2]

These high fat diet studies revealed that L. gasseri reduces mRNA expression of pro-inflammatory genes in white adipose tissue while enhancing genes involved in energy expenditure. Animals receiving the probiotic showed better lipid metabolism markers, including reduced triglycerides and improved cholesterol ratios—effects that translated to human trials.[16]

Synergy With Soil-Based Organisms

Soil-based organisms (SBOs) like Bacillus coagulans and various Bacillus subtilis strains offer unique advantages. These spore-forming bacteria survive digestive transit without special encapsulation, and they create environmental conditions that help other probiotic strains colonize.

SBOs produce antimicrobial peptides that inhibit pathogenic bacteria, effectively clearing space for beneficial organisms like Lactobacillus gasseri to establish themselves.[10] They also stimulate the production of mucin—the protective gut lining that serves as anchor points for probiotic colonization. This synergistic relationship explains why multi-strain formulations often outperform single-strain products.

Complementary Lactobacillus and Bifidobacterium Species

Research on Bifidobacterium lactis shows it enhances gut barrier function and reduces inflammatory markers that interfere with healthy metabolism.[11] When combined with Lactobacillus gasseri, these strains create a more comprehensive approach to microbiome optimization. Bifidobacterium lactis Bb12 has been studied alongside various Lactobacillus strains with positive results on body composition.

Similarly, Lactobacillus plantarum produces enzymes that break down complex fibers into simpler compounds that other beneficial bacteria can utilize more efficiently. This metabolic cooperation amplifies the benefits of each individual probiotic strain.[12]

Multi-strain formulations that include Lactobacillus gasseri alongside 8-10 complementary species consistently outperform single-strain products in real-world outcomes, even when total CFU counts remain similar. The synergy between different probiotic strains creates a more resilient and effective gut microbiota profile.

Practical Application: Maximizing Your Results

Understanding the science matters, but implementation determines outcomes. Here's how to apply this research to your daily routine.

Timing and Consistency

Most studies administered Lactobacillus gasseri with meals, particularly breakfast or dinner. Food buffers stomach acid, improving bacterial survival even in standard capsules. With acid-resistant delivery systems, timing becomes less critical, though consistency matters more.

Your gut microbiome responds to regular patterns. Taking probiotic supplements at the same time daily helps establish colonization rhythms that align with your digestive cycles. Missing occasional doses won't derail progress, but sporadic use prevents the stable colonization needed for metabolic benefits.

Supporting Your Microbiome Beyond Supplementation

Probiotic supplements work best as part of a broader gut health strategy. Your diet profoundly influences which bacteria thrive in your system. Consuming adequate fiber (25-35 grams daily) from vegetables, legumes, and whole grains provides the substrate beneficial bacteria need to flourish.

Prebiotic-rich foods like garlic, onions, asparagus, and under-ripe bananas complement supplemental prebiotics. These whole food sources contain diverse fiber types that feed different bacterial species, creating a more resilient microbiome ecosystem.

Minimizing processed foods, artificial sweeteners, and unnecessary antibiotics preserves the beneficial bacteria you're working to establish. Even the best probiotic supplement struggles to overcome a diet or lifestyle that continuously disrupts gut ecology.

What to Look for in a Quality Formulation

Not all probiotic products deliver what their labels promise. Third-party testing reveals that many supplements contain fewer viable organisms than claimed, or include strains different from those listed.[13]

Prioritize products that specify exact strains (not just species), provide guaranteed CFU counts at expiration (not manufacture), and use acid-resistant capsule technology. Formulations free from unnecessary fillers like microcrystalline cellulose, magnesium stearate, and silica dioxide ensure you're getting only what supports your gut health.

The presence of prebiotics within the same formula offers convenience, though you may need additional prebiotic supplementation depending on your dietary fiber intake. Look for products that include at least 2-3 grams of prebiotic fiber per serving to meaningfully support probiotic colonization.

gut lining cross-section showing how probiotics and prebiotics strengthen barrier function and gap junctions

Addressing Common Questions and Concerns

How Long Does It Take to See Results?

Body composition changes don't happen overnight. Clinical trials measuring visceral fat reduction typically show significant results at the 12-week mark, with some improvements visible as early as 8 weeks in overweight individuals.

You might notice digestive improvements—reduced bloating, more regular bowel movements—within the first 2-4 weeks. These early changes indicate successful colonization, though they don't necessarily predict fat loss outcomes. Patience and consistency through the full 12-week period gives Lactobacillus gasseri time to exert its metabolic effects on adipose tissue and body weight.

Can You Take Too Much?

Probiotic bacteria have an excellent safety profile, even at high doses. Studies using up to 100 billion CFU daily across various probiotic strains report no serious adverse events.[14] However, more isn't always better—your gut has limited colonization capacity, and excess bacteria simply pass through unabsorbed.

The 5-10 billion CFU range for Lactobacillus gasseri appears sufficient based on clinical evidence.

What About Side Effects?

Most people tolerate Lactobacillus gasseri without issues. When side effects occur, they're typically mild and transient—mild gas or bloating during the first week as your microbiome adjusts. These symptoms usually resolve as your gut adapts to the new bacterial residents.

If you have compromised immune function or serious underlying health conditions, consult your healthcare provider before starting any new supplement regimen. While probiotic supplements are generally safe, individual circumstances may warrant medical guidance.

The Bigger Picture: Probiotics as Part of Metabolic Health

It's important to maintain realistic expectations. Lactobacillus gasseri isn't a magic solution that melts away fat regardless of other lifestyle factors. Clinical studies showing significant results included participants who maintained relatively stable diets and activity levels—the probiotic worked alongside, not instead of, other healthy behaviors.

Research suggests this probiotic strain may help you get more metabolic benefit from the healthy choices you're already making. If you're eating well and moving regularly but struggling with stubborn abdominal fat, this is where targeted probiotic support can make a meaningful difference.[15]

Integration With Other Health Goals

Many people taking probiotic supplements for weight management notice improvements in areas beyond body composition. Better digestion, more stable energy, clearer skin, and improved mood frequently accompany gut health optimization. These whole-body benefits reflect the far-reaching influence of your microbiome on multiple physiological systems.

The immune system particularly benefits from L. gasseri colonization. Research shows that regular supplementation enhances immune function markers and may reduce susceptibility to common infections.[11] This immune support occurs alongside the metabolic benefits, making probiotic therapy a comprehensive health strategy rather than a single-purpose intervention.

The gut-brain axis means that supporting your microbiome can influence stress responses, sleep quality, and cognitive function—all factors that indirectly affect your ability to maintain healthy weight. Taking a comprehensive approach to gut health often produces more profound results than focusing narrowly on a single outcome.

Choosing a Complete Solution

Given everything we've discussed—the importance of delivery technology, prebiotic support, multi-strain synergy, and clean formulation—finding a product that addresses all these factors simultaneously simplifies your supplementation routine.

MicroBiome Restore was formulated specifically to address these evidence-based requirements. It delivers 15 Billion CFU of Lactobacillus gasseri (comfortably above clinical tests) alongside nine complementary probiotic strains, including carefully selected soil-based organisms that enhance colonization and create optimal conditions for beneficial bacteria to thrive.

The formula includes both inulin and acacia senegal as prebiotic support, ensuring your probiotics have the nutritional foundation they need to establish themselves effectively. Pullulan capsules protect the bacteria through stomach acid, maximizing viable delivery to your intestinal tract.

Perhaps most importantly, the formulation contains zero unnecessary fillers—no microcrystalline cellulose, no magnesium stearate, no silicon dioxide. Just the bacteria, their prebiotic food, and a clean delivery system. This commitment to formulation purity means you're getting exactly what the research shows works, without the additives that can interfere with probiotic viability and gut health.

MicroBiome Restore probiotic supplement bottle with key features and benefits displayed on a white background

For those serious about optimizing their gut microbiome and metabolic health, starting with a 30-day trial provides enough time to notice digestive improvements while committing to the full 12-week protocol gives the strain the time frame clinical studies show produces measurable body composition changes.

Moving Forward With Evidence-Based Strategy

The research on Lactobacillus gasseri and weight management continues to evolve, but current evidence provides clear guidance: 5-10 billion CFU daily, delivered in acid-resistant capsules, supported by adequate prebiotic fiber, and ideally paired with complementary probiotic strains.

This isn't about taking the highest dose possible or the newest trendy probiotic strain. It's about understanding how these organisms work, what they need to succeed in your gut environment, and how to create optimal conditions for them to exert their metabolic benefits.

Your gut microbiome is as unique as your fingerprint, which means individual responses vary. Some people see dramatic changes within 8 weeks, while others need the full 12-week period or longer. What matters most is consistency, quality supplementation, and supporting your microbiome with the dietary and lifestyle factors that allow beneficial bacteria to thrive.

Start with the evidence-based dose, choose a clean and comprehensive formulation, pair it with adequate prebiotic intake, and give the process time to work. The research shows this approach produces real, measurable improvements in body composition for many people—particularly those struggling with stubborn abdominal adiposity despite maintaining relatively healthy lifestyles.

References

  1. Jung, S. P., et al. (2013). Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial. Korean Journal of Family Medicine, 34(2), 80-89. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611107/
  2. Kang, J. H., et al. (2013). Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS ONE, 8(1), e54617. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0054617
  3. Kadooka, Y., et al. (2010). Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition, 64(6), 636-643. https://pubmed.ncbi.nlm.nih.gov/20216555/
  4. Sanchez, M., et al. (2017). Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition, 117(4), 566-576. https://pubmed.ncbi.nlm.nih.gov/28222814/
  5. Kim, J., et al. (2018). Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: A randomized, double-blind, placebo-controlled trial. Journal of Medicinal Food, 21(5), 454-461. https://pubmed.ncbi.nlm.nih.gov/29443664/
  6. Kadooka, Y., et al. (2013). Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition, 110(9), 1696-1703. https://pubmed.ncbi.nlm.nih.gov/23614897/
  7. Salminen, S., et al. (1998). Safety assessment of probiotics. Food and Nutrition Research, 42(0), 107-110. https://pubmed.ncbi.nlm.nih.gov/9602881/
  8. Cook, M. T., et al. (2012). Microencapsulation of probiotics for gastrointestinal delivery. Journal of Controlled Release, 162(1), 56-67. https://pubmed.ncbi.nlm.nih.gov/22698940/
  9. Roberfroid, M., et al. (2010). Prebiotic effects: Metabolic and health benefits. British Journal of Nutrition, 104(S2), S1-S63. https://pubmed.ncbi.nlm.nih.gov/20920376/
  10. Elshaghabee, F. M. F., et al. (2017). Bacillus as potential probiotics: Status, concerns, and future perspectives. Frontiers in Microbiology, 8, 1490. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539093/
  11. Akatsu, H., et al. (2013). Clinical effects of probiotic Bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding. Journal of Parenteral and Enteral Nutrition, 37(5), 631-640. https://pubmed.ncbi.nlm.nih.gov/23337342/
  12. de Vries, M. C., et al. (2006). Lactobacillus plantarum—survival, functional and potential probiotic properties in the human intestinal tract. International Dairy Journal, 16(9), 1018-1028. https://www.sciencedirect.com/science/article/abs/pii/S0958694605002918
  13. Morovic, W., et al. (2016). Assessing the accuracy of claims for probiotic supplements. Frontiers in Microbiology, 7, 1868. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112309/
  14. Hemarajata, P., & Versalovic, J. (2013). Effects of probiotics on gut microbiota: Mechanisms of intestinal immunomodulation and neuromodulation. Therapeutic Advances in Gastroenterology, 6(1), 39-51. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539293/
  15. John, G. K., & Mullin, G. E. (2016). The gut microbiome and obesity. Current Oncology Reports, 18(7), 45. https://pubmed.ncbi.nlm.nih.gov/27155989/
  16. Miyoshi, M., et al. (2014). Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. European Journal of Nutrition, 53(2), 599-606. https://pubmed.ncbi.nlm.nih.gov/23917447/
  17. Yun, S. I., et al. (2009). Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. Journal of Applied Microbiology, 107(5), 1681-1686. https://pubmed.ncbi.nlm.nih.gov/19457033/
  18. Marelli, G., et al. (2011). Efficacy of Lactobacillus plantarum on weight and fat loss in overweight subjects: A randomized controlled trial. Nutrition & Metabolism, 8, 48. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170059/
  19. Million, M., et al. (2012). Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. International Journal of Obesity, 36(6), 817-825. https://pubmed.ncbi.nlm.nih.gov/21829158/
  20. Delzenne, N. M., et al. (2011). Targeting gut microbiota in obesity: Effects of prebiotics and probiotics. Nature Reviews Endocrinology, 7(11), 639-646. https://pubmed.ncbi.nlm.nih.gov/21826100/
  21. Stenman, L. K., et al. (2016). Probiotic B. lactis 420 and prebiotic polydextrose reduce fat mass in subjects with increased abdominal fat. Beneficial Microbes, 7(4), 511-522. https://pubmed.ncbi.nlm.nih.gov/27213043/
  22. Wang, J., et al. (2015). Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME Journal, 9(1), 1-15. https://pubmed.ncbi.nlm.nih.gov/24936764/
  23. Gibson, G. R., et al. (2017). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology & Hepatology, 14(8), 491-502. https://pubmed.ncbi.nlm.nih.gov/28611480/
  24. Schellekens, H., et al. (2015). The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis? Neurochemistry International, 99, 110-132. https://pubmed.ncbi.nlm.nih.gov/26498265/
  25. Dahiya, D. K., et al. (2017). Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: A review. Frontiers in Microbiology, 8, 563. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380271/
  26. Sanders, M. E., et al. (2019). Probiotics and prebiotics in intestinal health and disease: From biology to the clinic. Nature Reviews Gastroenterology & Hepatology, 16(10), 605-616. https://pubmed.ncbi.nlm.nih.gov/31296969/
  27. Borgeraas, H., et al. (2018). Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: A systematic review and meta-analysis of randomized controlled trials. Obesity Reviews, 19(2), 219-232. https://pubmed.ncbi.nlm.nih.gov/29047207/
  28. Abenavoli, L., et al. (2019). Gut microbiota and obesity: A role for probiotics. Nutrients, 11(11), 2690. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893459/
  29. Turnbaugh, P. J., et al. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444(7122), 1027-1031. https://pubmed.ncbi.nlm.nih.gov/17183312/
  30. Ley, R. E., et al. (2005). Obesity alters gut microbial ecology. Proceedings of the National Academy of Sciences, 102(31), 11070-11075. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1176910/
  31. Minami, J., et al. (2015). Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: A randomized, double-blind, placebo-controlled trial. Bioscience of Microbiota, Food and Health, 34(4), 75-80. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722517/
  32. Kadooka, Y., et al. (2012). Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats. Journal of Dairy Science, 95(9), 4813-4825. https://pubmed.ncbi.nlm.nih.gov/22916887/
  33. Kondo, S., et al. (2010). Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity. Bioscience, Biotechnology, and Biochemistry, 74(8), 1656-1661. https://pubmed.ncbi.nlm.nih.gov/20699581/
  34. Rastall, R. A., & Gibson, G. R. (2015). Recent developments in prebiotics to selectively impact beneficial microbes and promote intestinal health. Current Opinion in Biotechnology, 32, 42-46. https://pubmed.ncbi.nlm.nih.gov/25448230/
  35. Sanders, M. E., et al. (2018). Shared mechanisms among probiotic taxa: Implications for general probiotic claims. Current Opinion in Biotechnology, 49, 207-216. https://pubmed.ncbi.nlm.nih.gov/29156403/